Dr. Olivier Rouvière, PhD[email protected]Clinical NewsJFR 2018: Must you perform prostate MRI before each biopsy?Most experts recommend MRI for patients with a history of systematic negative biopsies and in whom there is still a suspicion of prostate cancer, but the added value remains controversial, Dr. Olivier Rouvière, PhD, told delegates at the French national radiology congress (JFR 2018).October 15, 2018Page 1 of 1Top StoriesMolecular ImagingF-18 PSMA PET-CT proves clinical value in prostate cancerF-18 prostate-specific membrane antigen (PSMA) PET/CT is having a major impact on patient care and therapy decisions in prostate cancer, but it’s crucial to bear in mind the modality’s diagnostic quirks.Molecular ImagingCombined PET scans predict progression of Alzheimer’sMolecular ImagingPET scans predict outcomes for patients undergoing CAR T-cell therapyMRIMRI-based nomogram provides boost in breast cancerCTCT estimated to cause 5% of new cancer cases